These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9457190)

  • 1. Alendronate-induced esophagitis: case report of a recently recognized form of severe esophagitis with esophageal stricture--radiographic features.
    Ryan JM; Kelsey P; Ryan BM; Mueller PR
    Radiology; 1998 Feb; 206(2):389-91. PubMed ID: 9457190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esophagitis dissecans superficialis and alendronate: case report.
    Cameron RB
    Gastrointest Endosc; 1997 Dec; 46(6):562-3. PubMed ID: 9434230
    [No Abstract]   [Full Text] [Related]  

  • 3. [Alendronate-induced severe esophagitis. A rare and severe reversible side-effect illustrated by three case reports].
    Tóth E; Fork FT; Lindelöw K; Lindström E; Verbaan H; Veress B
    Lakartidningen; 1998 Aug; 95(35):3676-80. PubMed ID: 9748782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oesophageal stricture associated with alendronic acid.
    Naylor G; Davies MH
    Lancet; 1996 Oct; 348(9033):1030-1. PubMed ID: 8855876
    [No Abstract]   [Full Text] [Related]  

  • 5. [Alendronate-induced esophagitis. A report of 2 cases].
    Girelli CM; Reguzzoni G; Rocca F
    Recenti Prog Med; 1997 May; 88(5):223-5. PubMed ID: 9244956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophagitis associated with the use of alendronate.
    de Groen PC; Lubbe DF; Hirsch LJ; Daifotis A; Stephenson W; Freedholm D; Pryor-Tillotson S; Seleznick MJ; Pinkas H; Wang KK
    N Engl J Med; 1996 Oct; 335(14):1016-21. PubMed ID: 8793925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophagitis associated with alendronate sodium.
    Pizzani E; Valenzuela G
    Va Med Q; 1997; 124(3):181-2. PubMed ID: 9227047
    [No Abstract]   [Full Text] [Related]  

  • 8. Alendronate--risk for esophageal stricture.
    Yue QY; Mortimer O
    J Am Geriatr Soc; 1998 Dec; 46(12):1581-2. PubMed ID: 9848825
    [No Abstract]   [Full Text] [Related]  

  • 9. Alendronate-associated esophageal injury: pathologic and endoscopic features.
    Abraham SC; Cruz-Correa M; Lee LA; Yardley JH; Wu TT
    Mod Pathol; 1999 Dec; 12(12):1152-7. PubMed ID: 10619269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrosive esophagitis in children. Assessment by the esophagogram.
    Stannard MW
    Am J Dis Child; 1978 Jun; 132(6):596-9. PubMed ID: 655144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alendronate-induced esophagitis.
    CMAJ; 1998 Apr; 158(7):941-2, 945-6. PubMed ID: 9559022
    [No Abstract]   [Full Text] [Related]  

  • 12. Progressive roentgenographic appearance of caustic esophagitis.
    Chen YM; Ott DJ; Thompson JN; Gelfand DW
    South Med J; 1988 Jun; 81(6):724-8, 744. PubMed ID: 3375877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Esophagitis associated with use of alendronate in 5 postmenopausic patients].
    Luciani J; Pigatto V; Naves A; Fay M; Silvestre Begnis M; Piola JC; Prada DB; Pedrana R
    Acta Gastroenterol Latinoam; 2001 May; 31(2):59-63. PubMed ID: 11471319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug-induced esophagitis: can stringent indications help prevent this disease picture?].
    Weihrauch TR
    Z Gastroenterol; 1997 Jun; 35(6):525-7. PubMed ID: 9281245
    [No Abstract]   [Full Text] [Related]  

  • 15. Esophageal stenosis caused by alendronate.
    Aibar Arregui MA; de Escalante Yangüela B; Muñoz Villalengua M; Garcés Horna V
    Rev Esp Enferm Dig; 2011 Jun; 103(6):338-9. PubMed ID: 21736407
    [No Abstract]   [Full Text] [Related]  

  • 16. Lowering the risk of esophagitis from alendronate therapy.
    Chase JL
    Am J Health Syst Pharm; 1998 May; 55(9):892-3. PubMed ID: 9588247
    [No Abstract]   [Full Text] [Related]  

  • 17. Atypical femoral fractures shortly after osteonecrosis of the jaw in a postmenopausal woman taking alendronate for osteoporosis.
    Chiu WY; Lee JJ; Tsai KS
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E723-6. PubMed ID: 23471975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ulcerative esophagitis associated with the use of alendronate sodium: histopathological and endoscopic features].
    Fernandes PA; Pires MS; Gouvêa AP
    Arq Gastroenterol; 2002; 39(3):173-6. PubMed ID: 12778309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esophageal stricture associated with alendronate use.
    Paul AK; Seetharaman M
    CMAJ; 2011 Apr; 183(7):E429. PubMed ID: 21343270
    [No Abstract]   [Full Text] [Related]  

  • 20. United Kingdom experience with alendronate and oesophageal reactions.
    Mackay FJ; Wilton LV; Pearce GL; Freemantle SN; Mann RD
    Br J Gen Pract; 1998 Apr; 48(429):1161-2. PubMed ID: 9667093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.